Fluofarma is a leading company in High Content Screening (HCS) providing services
to improve the drug discovery potential of its clients.

The Fluofarma divisions provide the most complete High Content Screening
service offer on the market.

Bioengineering

Development of new cell-based assay
Customization of existing cell-based assay
Miniaturization of cell-based assay
Mechanism of Action studies

Bioscreening

Portfolio of over 600 cell-based assays
By cellular fonction
By therapeutic domains

Biocomputing

Customized software solutions for image and signal processing
Image quantification and data analysis from HCS experiments
Cytosurfer®: a ready to use image data analysis software
    for HCS &HCA

 

 

 

CytoSurfer® is a ready to use image data analysis software for High Content Screening
(HCS).


CytoSurfer® efficiently bridges flow cytometry and image analysis visualizing data through
interactive multidimensional scatter plots which allow to identify and visualize subpopulations
of cells.

► In one click with Cytosurfer® you can:

Select and independently analyze different cell populations
Go back and forth between graphs and original cell images
Load plate layouts (96 or 384 wells) to regroup and analyze well replicates
Analyze data statistically and generate comprehensive reports

Please visit the CytoSurfer® website for more information and obtain a demo version.

 

Breaking news

  • High Content Analysis 2012

    Fluofarma will be attending the High Content Analysis 2012 in San Francisco, from January 9th to 12th. We look forward to seeing you at our booth (n° 34) and your are welcome the 11th at the « Luncheon Technology Showcase: High-Content Data Analysis » where Fluofarma will present CytoSurfe®r. An innovative and intuitive software application for High content image analysis.

    Read more [+]

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal "The American Journal of Pathology".

    Read more [+]